Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells-Reference-Cited by-同舟云学术

Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells

Published:2019-02 Issue:7743 Volume:566 Page:270-274
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Han Dali,Liu Jun,Chen Chuanyuan,Dong Lihui,Liu Yi,Chang Renbao,Huang Xiaona,Liu Yuanyuan,Wang Jianying,Dougherty Urszula,Bissonnette Marc B.,Shen Bin,Weichselbaum Ralph R.,Xu Meng Michelle,He Chuan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-0916-x.pdf

Reference40 articles.

1. Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015).

2. Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217–221 (2017).

3. Yarchoan, M., Johnson, B. A. III, Lutz, E. R., Laheru, D. A. & Jaffee, E. M. Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer 17, 209–222 (2017).

4. Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222–226 (2017).

5. Wang, X. et al. N 6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388–1399 (2015).

Cited by 726 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics of lupus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Epigenetic modifications in hematopoietic ecosystem: a key tuner from homeostasis to acute myeloid leukemia;Blood Science;2024-09-12

3. METTL3 inhibition-activated cGAS/STING axis enhances immunotherapy and PARP inhibitor sensitivity of lung carcinoma;2024-09-06

4. Benzo(a)pyrene promotes the malignant progression of malignant-transformed BEAS-2B cells by regulating YTH N6-methyladenosine RNA binding protein 1 to inhibit ferroptosis;Toxicology;2024-09

5. RNA modifications in physiology and pathology: Progressing towards application in clinical settings;Cellular Signalling;2024-09